Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LOC729915///LOC728093///POM121L3P///POM121L10P///LOC440821///POM121L4P///POM121L8P///POM121L9P///POM121L1P |
| Upstream (Parents) |
|---|
| (<<) PPEF2 → LOC729915///LOC728093///POM121L3P///POM121L10P///LOC440821///POM121L4P///POM121L8P///POM121L9P///POM121L1P |
| (<<) SP3P → LOC729915///LOC728093///POM121L3P///POM121L10P///LOC440821///POM121L4P///POM121L8P///POM121L9P///POM121L1P |
| (<<) MAGEA9B///MAGEA9 → LOC729915///LOC728093///POM121L3P///POM121L10P///LOC440821///POM121L4P///POM121L8P///POM121L9P///POM121L1P |
| (<<) TRIL → LOC729915///LOC728093///POM121L3P///POM121L10P///LOC440821///POM121L4P///POM121L8P///POM121L9P///POM121L1P |
| (<<) GALK1 → LOC729915///LOC728093///POM121L3P///POM121L10P///LOC440821///POM121L4P///POM121L8P///POM121L9P///POM121L1P |
| (<<) AFP → LOC729915///LOC728093///POM121L3P///POM121L10P///LOC440821///POM121L4P///POM121L8P///POM121L9P///POM121L1P |
| (<<) TLR3 → LOC729915///LOC728093///POM121L3P///POM121L10P///LOC440821///POM121L4P///POM121L8P///POM121L9P///POM121L1P |
| (<<) CBR3 → LOC729915///LOC728093///POM121L3P///POM121L10P///LOC440821///POM121L4P///POM121L8P///POM121L9P///POM121L1P |
| Downstream (Children) |
|---|
| LOC729915///LOC728093///POM121L3P///POM121L10P///LOC440821///POM121L4P///POM121L8P///POM121L9P///POM121L1P → GMPR (>>) |
| LOC729915///LOC728093///POM121L3P///POM121L10P///LOC440821///POM121L4P///POM121L8P///POM121L9P///POM121L1P → LMO1 (>>) |
| LOC729915///LOC728093///POM121L3P///POM121L10P///LOC440821///POM121L4P///POM121L8P///POM121L9P///POM121L1P → PAK4 (>>) |
